Last updated: February 21, 2026
What is NDC 70677-1180?
NDC 70677-1180 refers to a specific pharmaceutical product listed in the National Drug Code directory. Based on available data, it corresponds to Fluticasone Propionate Nasal Spray, 50 mcg per spray. The drug is used to treat allergic rhinitis and nasal congestion.
Market Landscape
Market Size and Penetration
The global allergic rhinitis market was valued at approximately USD 8.4 billion in 2022, with an expected compound annual growth rate (CAGR) of 4.2% through 2030 [1]. The nasal corticosteroids segment holds the highest market share due to efficacy and safety profiles.
Key Competitors
The main competitors include:
- Fluticasone propionate (brand names: Flonase, Xhance)
- Mometasone furoate
- Triamcinolone acetonide
Market leaders such as GlaxoSmithKline and AstraZeneca dominate with established brands and broad distribution channels.
Market Penetration for NDC 70677-1180
As a generic or store-brand equivalent, NDC 70677-1180's market penetration depends on:
- Distribution agreements
- Pricing strategies
- Physician prescribing behavior
- Consumer demand trends
Pricing Trends and Projections
Current Pricing
The average wholesale price (AWP) of Fluticasone nasal spray ranges from USD 40 to USD 60 per 120-dose bottle [2].
- NDC 70677-1180’s retail price is approximately USD 15-20 per 120-dose bottle, positioned as a lower-cost alternative.
- Pharma wholesalers typically sell at 10-15% below AWP, creating room for profit margins.
Price Trends (2020-2023)
- Steady decrease in generic nasal spray prices, driven by generic competition.
- Price erosion of approximately 5-7% annually in the nascent stages post-generic approval.
- Retail prices stabilized in 2022-2023, indicating a mature generic segment with limited further reductions.
Forecasted Pricing (2024-2028)
- Prices are expected to stabilize with minor fluctuations, maintaining around USD 15-20 for typical package sizes.
- The entry of biosimilars or improved formulations could alter prices marginally, but current trends suggest stability.
Factors Affecting Future Prices
- Market saturation of generic nasal corticosteroids.
- Regulatory policies impacting drug pricing.
- Insurance formulary placements favoring generics.
- Potential new formulations that may replace traditional sprays.
Regulatory and Patent Landscape
Patent Status
- Original patents for Fluticasone expired around 2018 [3].
- Patent challenges and exclusivity periods for some formulations could influence generic entry dates.
Regulatory Environment
- FDA approval processes favor rapid approval of generics post-patent expiry.
- Price negotiation policies in Medicare and private payers may cap pricing.
Strategic Implications
- Companies manufacturing NDC 70677-1180 should focus on maintaining cost leadership.
- Expansion into emerging markets can capitalize on low-cost alternatives.
- Monitoring regulatory changes and patent developments remains critical.
Key Takeaways
- NDC 70677-1180 represents a low-cost generic nasal spray with stable market positioning.
- Market size for nasal corticosteroids is robust, projected to grow modestly.
- Price stability is expected through 2028, with minor decreases driven by competitive dynamics.
- Market leaders’ dominance and patent expirations enable rapid entry and competition.
- Payers and regulatory policies influence pricing trends significantly.
FAQs
1. How does NDC 70677-1180 compare to branded fluticasone products?
It offers a similar active ingredient at approximately half the retail price, targeting cost-sensitive consumers.
2. What are the main drivers for market growth for nasal corticosteroids?
Increasing prevalence of allergic rhinitis, rising awareness of over-the-counter options, and expanding prescription coverage.
3. When is the next significant price change expected?
Given current market stability, significant price shifts are unlikely before 2025 unless new competitors or formulations enter.
4. Are there supply chain risks associated with NDC 70677-1180?
Generic production is generally stable, but supply disruptions could occur due to raw material shortages or regulatory issues.
5. What factors could influence the entry of biosimilars or alternative therapies?
Patent expirations, regulatory pathways, and shifts toward novel delivery systems may impact future market share.
References
[1] Grand View Research. (2022). Allergic Rhinitis Market Size, Share & Trends.
[2] GoodRx. (2023). Nasal Spray Price Comparison.
[3] U.S. Patent and Trademark Office. (2018). Patent Expiration Dates for Fluticasone.
Note: Exact formulation and packaging details for NDC 70677-1180 should be verified through the latest FDA records or manufacturer disclosures.
